These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36130384)

  • 1. Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges.
    Fernández-Deaza G; Caicedo-Martínez M; Serrano B; Roura E; Castillo JS; De Sanjosé S; Bruni L; Murillo R
    Salud Publica Mex; 2022 Jul; 64(4, jul-ago):415-423. PubMed ID: 36130384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of HPV testing in Latin America.
    Jeronimo J; Holme F; Slavkovsky R; Camel C
    J Clin Virol; 2016 Mar; 76 Suppl 1():S69-S73. PubMed ID: 26699418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
    Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical precancer and invasive cancer among women living with HIV in Latin America: A systematic review and meta-analysis.
    Fernández-Deaza G; Negrete-Tobar G; Caicedo M; Téllez N; Mello MB; Ghidinelli M; Nuche-Berenguer B; Murillo R
    Int J STD AIDS; 2024 Nov; 35(13):1008-1018. PubMed ID: 39222397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
    Asangbeh-Kerman SL; Davidović M; Taghavi K; Kachingwe J; Rammipi KM; Muzingwani L; Pascoe M; Jousse M; Mulongo M; Mwanahamuntu M; Tapela N; Akintade O; Basu P; Dlamini X; Bohlius J
    BMC Public Health; 2022 Aug; 22(1):1530. PubMed ID: 35948944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer control in Latin America: A call to action.
    Bychkovsky BL; Ferreyra ME; Strasser-Weippl K; Herold CI; de Lima Lopes G; Dizon DS; Schmeler KM; Del Carmen M; Randall TC; Nogueira-Rodrigues A; de Carvalho Calabrich AF; St Louis J; Vail CM; Goss PE
    Cancer; 2016 Feb; 122(4):502-14. PubMed ID: 26670695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
    Bruni L; Serrano B; Roura E; Alemany L; Cowan M; Herrero R; Poljak M; Murillo R; Broutet N; Riley LM; de Sanjose S
    Lancet Glob Health; 2022 Aug; 10(8):e1115-e1127. PubMed ID: 35839811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV Testing in Resource-Limited Settings: How Can We Reach the Next Level of Cervical Cancer Screening in Latin America and the Caribbean?
    Randall TC; Salicrup LA; Luciani S; Trimble EL
    Oncologist; 2015 Oct; 20(10):1101-4. PubMed ID: 26330459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Hall MT; Smith MA; Simms KT; Barnabas R; Murray JM; Canfell K
    Int J Cancer; 2021 Jul; 149(2):297-306. PubMed ID: 33634857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Systematic Review of Human Papillomavirus Genotype Distribution by Cervical Disease Grade in Women Living With Human Immunodeficiency Virus Highlights Limited Findings From Latin America.
    Dickey BL; Coghill AE; Ellsworth GB; Wilkin TJ; Villa LL; Giuliano AR
    Sex Transm Dis; 2021 Dec; 48(12):e248-e254. PubMed ID: 34110738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Maver PJ; Poljak M
    Clin Microbiol Infect; 2020 May; 26(5):579-583. PubMed ID: 31539637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New paradigms and challenges in cervical cancer prevention and control in Latin America].
    Almonte M; Murillo R; Sánchez GI; Jerónimo J; Salmerón J; Ferreccio C; Lazcano-Ponce E; Herrero R
    Salud Publica Mex; 2010; 52(6):544-59. PubMed ID: 21271014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of cervical cancer in Latin America.
    Bosch FX
    Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.